Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

CeloNova Cobra Pzf stent
Technology | Stents | March 02, 2017

March 2, 2017 — The U.S. Food and Drug Administration (FDA) cleared CeloNova BioSciences Inc. first-in-class Cobra...

ACC, Haymarket Medical Education, HME, myCME, RightSTEPS initiative, prescribing behavior, chronic heart failure
News | Heart Failure | February 22, 2017

February 22, 2017 — The American College of Cardiology (ACC), Haymarket Medical Education (HME) and myCME have...

Xarelto, rivaroxaban, COMPASS study, ends early,
News | Antiplatelet and Anticoagulation Therapies | February 09, 2017

February 9, 2017 — Janssen Research & Development LLC (Janssen) announced that the Phase 3 COMPASS trial is...

GE Healthcare, Rapiscan stress imaging agent, North America, Rapidscan Pharma Solutions Inc.
News | Pharmaceuticals | February 07, 2017

February 7, 2017 — GE Healthcare’s Life Sciences business announced in January that it acquired Rapidscan Pharma...

The Xprecia Stride Coagulation Analyzer delivers fast, reliable prothrombin time/international normalized ratio (PT/INR) testing for point-of-care monitoring and management of oral anticoagulation therapy with warfarin, a vitamin K antagonist. It is the latest INR testing system to enter the market in late 2016. Read the article “Siemens Receives FDA Clearance of Xprecia Stride Coagulation Analyzer.”
 

 

Feature | Point of Care Testing | December 30, 2016 | Ravi Chawat

Point of care testing devices are gaining widespread approval for prompt medical diagnoses, especially in cardiology...

Heart attack, heart failure, Cimaglermin
News | Pharmaceuticals | December 28, 2016

December 28, 2016 — Cimaglermin, a new experimental drug, may help restore cardiac function after heart failure,...

harmful drug interactions, big data, JACC study, drug-drug interaction, Nicholas Tatonetti
News | Pharmaceuticals | December 13, 2016

December 13, 2016 — Coupling data mining of adverse event reports and electronic health records with targeted...

INRatio, Alere, Abbott, I and R testing, INR testing
Feature | Point of Care Testing | December 07, 2016

December 7, 2016 — Abbott has filed a complaint to terminate its proposed acquisition of Alere based on the...

Videos | TCT | November 18, 2016

DAIC Editor Dave Fornell takes a video tour of some of the most innovative new interventional cardiology...

Siemens, FDA clearance, Xprecia Stride Coagulation Analyzer, point-of-care testing
Technology | Point of Care Testing | November 10, 2016

November 10, 2016 — Siemens Healthineers announced U.S. Food and Drug Administration (FDA) 510(k) clearance for a...

Aggrastat Bolus Vial, IV antiplatelet agent
Technology | Antiplatelet and Anticoagulation Therapies | October 28, 2016

October 28, 2016 — Medicure Inc. recently received U.S. Food and Drug Administration (FDA) market clearance for its...

Overlay Init